Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Acta cir. bras ; 35(1): e202000105, 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1088523

RESUMO

Abstract Purpose To investigate whether heat shock protein 90 (HSP90) is involved in complement regulation in ischemic postconditioning (IPC). Methods The left coronary artery of rats underwent 30 min of occlusion, followed by 120 min of reperfusion and treatment with IPC via 3 cycles of 30s reperfusion and 30s occlusion. The rats were injected intraperitoneally with 1 mg/kg HSP90 inhibitor geldanamycin (GA) after anesthesia. Eighty rats were randomly divided into four groups: sham, ischemia-reperfusion (I/R), IPC and IPC + GA. Myocardial infarct size, apoptosis index and the expression of HSP90, C3, C5a, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1β and c-Jun N-terminal kinase (JNK) were assessed. Results Compared with the I/R injury, the IPC treatment significantly reduced infarct size, release of troponin T, creatine kinase-MB, and lactate dehydrogenase, and cardiomyocyte apoptosis. These beneficial effects were accompanied by a decrease in TNF-α, IL-1β, C3, C5a and JNK expression levels. However, all these effects were abrogated by administration of the HSP90 inhibitor GA. Conclusion HSP90 exerts a profound effect on IPC cardioprotection, and may be linked to the inhibition of the complement system and JNK, ultimately attenuating I/R-induced myocardial injury and apoptosis.


Assuntos
Animais , Ratos , Proteínas do Sistema Complemento/metabolismo , Traumatismo por Reperfusão Miocárdica/metabolismo , Benzoquinonas/farmacologia , Proteínas de Choque Térmico HSP90/antagonistas & inibidores , Lactamas Macrocíclicas/farmacologia , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Infarto do Miocárdio/metabolismo , RNA Mensageiro/metabolismo , Distribuição Aleatória , Fator de Necrose Tumoral alfa/metabolismo , Ratos Sprague-Dawley , Mediadores da Inflamação , Creatina Quinase Forma MB/metabolismo , Pós-Condicionamento Isquêmico/métodos
2.
Yonsei Medical Journal ; : 522-526, 2011.
Artigo em Inglês | WPRIM | ID: wpr-181466

RESUMO

Helicobacter pylori (H. pylori) is an important risk factor for chronic gastritis, peptic ulcer, and gastric cancer. Proteinase-activated receptor 2 (PAR2), subgroup of G-protein coupled receptor family, is highly expressed in gastric cancer, and chronic expression of cyclooxygenase-2 (COX-2) plays an important role in H. pylori-associated gastric carcinogenesis and inflammation. We previously demonstrated that H. pylori induced the expression of PAR2 and COX-2 in gastric epithelial cells. Present study aims to investigate whether COX-2 expression induced by H. pylori in Korean isolates is mediated by PAR2 via activation of Gi protein and Src kinase in gastric epithelial AGS cells. Results showed that H. pylori-induced COX-2 expression was inhibited in the cells transfected with antisense oligonucleotide for PAR2 or treated with Gi protein blocker pertussis toxin, Src kinase inhibitor herbimycin A and soybean trypsin inbitor, indicating that COX-2 expression is mediated by PAR2 through activation of Gi protein and Src kinase in gastric epithelial cells infected with H. pylori in Korean isolates. Thus, targeting the activation of PAR2 may be beneficial for prevention or treatment of gastric inflammation and carcinogenesis associated with H. pylori infection.


Assuntos
Humanos , Benzoquinonas/farmacologia , Linhagem Celular Tumoral , Ciclo-Oxigenase 2/genética , Células Epiteliais/enzimologia , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/metabolismo , Mucosa Gástrica/enzimologia , Helicobacter pylori , Lactamas Macrocíclicas/farmacologia , Oligonucleotídeos Antissenso , Toxina Pertussis/farmacologia , RNA Mensageiro/metabolismo , Receptor PAR-2/fisiologia , Quinases da Família src/metabolismo
3.
Braz. j. med. biol. res ; 41(5): 403-410, May 2008. ilus
Artigo em Inglês | LILACS | ID: lil-484433

RESUMO

Intrahippocampal administration of kainic acid (KA) induces synaptic release of neurotrophins, mainly brain-derived neurotrophic factor, which contributes to the acute neuronal excitation produced by the toxin. Two protein tyrosine kinase inhibitors, herbimycin A and K252a, were administered intracerebroventricularly, in a single dose, to attenuate neurotrophin signaling during the acute effects of KA, and their role in epileptogenesis was evaluated in adult, male Wistar rats weighing 250-300 g. The latency for the first Racine stage V seizure was 90 ± 8 min in saline controls (N = 4) which increased to 369 ± 71 and 322 ± 63 min in animals receiving herbimycin A (1.74 nmol, N = 4) and K252a (10 pmol, N = 4), respectively. Behavioral alterations were accompanied by diminished duration of EEG paroxysms in herbimycin A- and K252a-treated animals. Notwithstanding the reduction in seizure severity, cell death (60-90 percent of cell loss in KA-treated animals) in limbic regions was unchanged by herbimycin A and K252a. However, aberrant mossy fiber sprouting was significantly reduced in the ipsilateral dorsal hippocampus of K252a-treated animals. In this model of temporal lobe epilepsy, both protein kinase inhibitors diminished the acute epileptic activity triggered by KA and the ensuing morphological alterations in the dentate gyrus without diminishing cell loss. Our current data indicating that K252a, but not herbimycin, has an influence over KA-induced mossy fiber sprouting further suggest that protein tyrosine kinase receptors are not the only factors which control this plasticity. Further experiments are necessary to elucidate the exact signaling systems associated with this K252a effect.


Assuntos
Animais , Masculino , Ratos , Benzoquinonas/farmacologia , Carbazóis/farmacologia , Epilepsia do Lobo Temporal/fisiopatologia , Alcaloides Indólicos/farmacologia , Ácido Caínico/antagonistas & inibidores , Lactamas Macrocíclicas/farmacologia , Fibras Musgosas Hipocampais/efeitos dos fármacos , Proteínas Tirosina Quinases/antagonistas & inibidores , Análise de Variância , Morte Celular/efeitos dos fármacos , Morte Celular/fisiologia , Eletroencefalografia , Inibidores Enzimáticos/farmacologia , Epilepsia do Lobo Temporal/induzido quimicamente , Epilepsia do Lobo Temporal/patologia , Agonistas de Aminoácidos Excitatórios/farmacologia , Ácido Caínico/farmacologia , Sistema Límbico/citologia , Sistema Límbico/efeitos dos fármacos , Fibras Musgosas Hipocampais/patologia , Fibras Musgosas Hipocampais/fisiopatologia , Fatores de Crescimento Neural , Ratos Wistar , Estatísticas não Paramétricas , Convulsões/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA